1H NMR metabolic profiling analysis offers evaluation of Nilestriol treatment in ovariectomised rats

Molecular and Cellular Endocrinology

Volumn 387, Issue 1-2, 2014, Pages 19-34

  Liu, Yan Ru ^a,b   Huang, Rong Qing ^b   Xiao, Bing Kun ^b   Yang, Jian Yun ^b   Dong, Jun Xing ^a,b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Metabolic profiling; Metabonomic; Nilestriol; Ovariectomy

Indexed keywords

AGENTS AFFECTING METABOLISM; GLUCOSE; INSULIN; NILESTRIOL; UNCLASSIFIED DRUG; ESTRIOL; INDICAN; LACTIC ACID;

ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; INSULIN RESISTANCE; MENOPAUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RAT; SKIN TEMPERATURE; TEMPERATURE SENSITIVITY; URINALYSIS; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLOME; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PHYSIOLOGY; SERUM; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; BODY WEIGHT; ESTRIOL; FEMALE; INDICAN; INSULIN RESISTANCE; LACTIC ACID; MENOPAUSE; METABOLOME; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SERUM; URINE;

EID: 84895836008     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.02.007     Document Type: Article

References (68)

1. Aboud O.A., Weiss R.H. New opportunities from the cancer metabolome. Clin. Chem. 2013, 59(1):138-146.
2. Aytan N., Choi J.K., Carreras I., Kowall N.W., Jenkins B.G., Dedeoglu A. Combination therapy in a transgenic model of Alzheimer's disease. Exp. Neurol. 2013, 250:228-238.
3. Banos G., Perez-Torres I., El Hafidi M. Medicinal agents in the metabolic syndrome. Cardiovasc Hematol. Agents Med. Chem. 2008, 6(4):237-252.
4. Barros R.P., Morani A., Moriscot A., Machado U.F. Insulin resistance of pregnancy involves estrogen-induced repression of muscle GLUT4. Mol. Cell. Endocrinol. 2008, 295(1-2):24-31.
5. Bernini P., Bertini I., Luchinat C., Tenori L., Tognaccini A. The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples. J. Proteome Res. 2011, 10(11):4983-4992.
6. Brattstrom L.E., Hultberg B.L., Hardebo J.E. Folic acid responsive postmenopausal homocysteinemia. Metabolism 1985, 34(11):1073-1077.
7. Brosnan J.T., Brosnan M.E. Creatine metabolism and the urea cycle. Mol. Genet. Metab. 2010, 100(Suppl 1):S49-52.
8. Chen J., Xu Y., Zhang J., Liu Z., Xu C., Zhang K., Shen Y., Xu Q. Genotypic association of the DAOA gene with resting-state brain activity in major depression. Mol. Neurobiol. 2012, 46(2):361-373.
9. Choi B.G., Vilahur G., Zafar M.U., Cardoso L., Yadegar D., Ibanez B., Tunstead J., Viles-Gonzalez J.F., Schaffler M.B., Fuster V., Badimon J.J. Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model. Atherosclerosis 2008, 201(1):76-84.
10. Deng H., Zhou H., Sun M. Roles of sex hormones and oxygen free radical in coronary heart disease. Hunan Yi Ke Da Xue Xue Bao 1999, 24(4):343-346.
11. Diamond-Stanic M.K., Romero-Aleshire M.J., Hoyer P.B., Greer K., Hoying J.B., Brooks H.L. Midkine, a heparin-binding protein, is increased in the diabetic mouse kidney postmenopause. Am. J. Physiol. Renal Physiol. 2011, 300(1):F139-146.
12. Dieterle F., Riefke B., Schlotterbeck G., Ross A., Senn H., Amberg A. NMR and MS methods for metabonomics. Methods Mol. Biol. 2011, 691:385-415.
13. Downs J.L., Wise P.M. The role of the brain in female reproductive aging. Mol. Cell. Endocrinol. 2009, 299(1):32-38.
14. Elliott J.O., Jacobson M.P., Haneef Z. Homocysteine and bone loss in epilepsy. Seizure 2007, 16(1):22-34.
15. Errico F., Napolitano F., Nistico R., Usiello A. New insights on the role of free D-aspartate in the mammalian brain. Amino Acids 2012, 43(5):1861-1871.
16. Gotoh K., Masaki T., Chiba S., Higuchi K., Kakuma T., Shimizu H., Mori M., Sakata T., Yoshimatsu H. Hypothalamic neuronal histamine signalling in the estrogen deficiency-induced obesity. J. Neurochem. 2009, 110(6):1796-1805.
17. Hawkins R.A., Killen E., Tesdale A.L., Sangster K., Thomson M., Steele R.J., Blackie R.A. Oestrogen receptors, lactate dehydrogenase and cellularity in human breast cancer. Clin. Chim. Acta 1988, 175(1):89-96.
18. Holmes E., Loo R.L., Stamler J., Bictash M., Yap I.K., Chan Q., Ebbels T., De Iorio M., Brown I.J., Veselkov K.A., Daviglus M.L., Kesteloot H., Ueshima H., Zhao L., Nicholson J.K., Elliott P. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453(7193):396-400.
19. Hubing K.A., Wingo J.E., Brothers R.M., Del Coso J., Low D.A., Crandall C.G. Nitric oxide synthase inhibition attenuates cutaneous vasodilation during postmenopausal hot flash episodes. Menopause - J. North Am. Menopause Soc. 2010, 17(5):978-982.
20. Illig T., Gieger C., Zhai G., Romisch-Margl W., Wang-Sattler R., Prehn C., Altmaier E., Kastenmuller G., Kato B.S., Mewes H.W., Meitinger T., de Angelis M.H., Kronenberg F., Soranzo N., Wichmann H.E., Spector T.D., Adamski J., Suhre K. A genome-wide perspective of genetic variation in human metabolism. Nat. Genet. 2010, 42(2):137-141.
21. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991, 15(3):175-191.
22. Kang L., Chen C.H., Cheng Y.C., Chang C.H., Lee C.T., Chang J.K., Cheng J.T., Chang F.M. Glucosamine-induced insulin resistance in ovariectomized rats is relevant to decreasing the expression of glucose transport protein subtype 4 in the skeletal muscle and in increasing the size of pancreatic islets. Menopause 2012, 19(5):496-502.
23. Kasaoka S., Kawahara Y., Inoue S., Tsuji M., Kato H., Tsuchiya T., Okuda H., Nakajima S. Gender effects in dietary histidine-induced anorexia. Nutrition 2005, 21(7-8):855-858.
24. Khan S.R., Baghdasarian A., Fahlman R.P., Michail K., Siraki AG. Current status and future prospects of toxicogenomics in drug discovery. Drug Discov. Today 2013.
25. Kim C., Edelstein S.L., Crandall J.P., Dabelea D., Kitabchi A.E., Hamman R.F., Montez M.G., Perreault L., Foulkes M.A., Barrett-Connor E. Menopause and risk of diabetes in the Diabetes Prevention Program. Menopause 2011, 18(8):857-868.
26. Larson E.B., Carroll M.E. Estrogen receptor beta, but not alpha, mediates estrogen's effect on cocaine-induced reinstatement of extinguished cocaine-seeking behavior in ovariectomized female rats. Neuropsychopharmacology 2007, 32(6):1334-1345.
27. Liu H., Xu K., Tan J., Yang S. Effects of Nilestriol on reproductive system in ovariectomized rats. Hua Xi Yi Ke Da Xue Xue Bao 2000, 31(1):65-67.
28. Liu Y., Huang R., Liu L., Peng J., Xiao B., Yang J., Miao Z., Huang H. Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy. J. Pharm. Biomed. Anal. 2010, 52(1):136-141.
29. Lochner C., Hemmings S.M., Kinnear C.J., Moolman-Smook J.C., Corfield V.A., Knowles J.A., Niehaus D.J., Stein D.J. Gender in obsessive-compulsive disorder: clinical and genetic findings. Eur. Neuropsychopharmacol. 2004, 14(2):105-113.
30. 1H NMR-based metabonomics analysis of plasma from osteoporotic rats induced by ovariectomy. Sichuan Da Xue Xue Bao Yi Xue Ban 2009, 40(5):843-847.
31. Ma B., Zhang Q., Wang G.J., A J.Y., Wu D., Liu Y., Cao B., Liu L.S., Hu Y.Y., Wang Y.L., Zheng Y.Y. GC-TOF/MS-based metabolomic profiling of estrogen deficiency-induced obesity in ovariectomized rats. Acta Pharmacol. Sin. 2011, 32(2):270-278.
32. Ma B., Li X.T., Zhang Q., Wu D., Wang G.J., Jiye A., Sun J.G., Li J., Liu Y.H., Wang Y.L., Ying H.J. Metabonomic profiling in studying anti-osteoporosis effects of strontium fructose 1,6-diphosphate on estrogen deficiency-induced osteoporosis in rats by GC/TOF-MS. Eur. J. Pharmacol. 2013, 718(1-3):524-532.
33. Ma B., Liu J.N., Zhang Q., Ying H.J., Jiye A., Sun J.G., Wu D., Wang Y.L., Li J., Liu Y.H. Metabolomic profiles delineate signature metabolic shifts during estrogen deficiency-induced bone loss in rat by GC-TOF/MS. PLoS ONE 2013, 8(2).
34. Madeira C., Freitas M.E., Vargas-Lopes C., Wolosker H., Panizzutti R. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr. Res. 2008, 101(1-3):76-83.
35. Maturana M.A., Irigoyen M.C., Spritzer P.M. Menopause, estrogens, and endothelial dysfunction: current concepts. Clinics (Sao Paulo) 2007, 62(1):77-86.
36. McCarthy M.M. What can development teach us about menopause?. Brain Res. 2011, 1379:109-118.
37. McCleland M.L., Adler A.S., Shang Y., Hunsaker T., Truong T., Peterson D., Torres E., Li L., Haley B., Stephan J.P., Belvin M., Hatzivassiliou G., Blackwood E.M., Corson L., Evangelista M., Zha J., Firestein R. An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer. Cancer Res. 2012, 72(22):5812-5823.
38. Munehiko Ikeda T.E., Yamauchi Atsushi, Sohda Yoshio, Koga Ayako, Kohji Tominaga H.S., Kataoka Yasufumi Selective serotonin reuptake inhibitors fluvoxamine and paroxetine restore forced exercise-induced temperature dysregulation in ovariectomized mice. Eur. J. Pharmacol. 2008, 579:439-444.
39. Nawata H., Tanaka S., Takayanagi R., Sakai Y., Yanase T., Ikuyama S., Haji M. Aromatase in bone cell: association with osteoporosis in postmenopausal women. J. Steroid Biochem. Mol. Biol. 1995, 53(1-6):165-174.
40. Newsholme P. Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection?. J. Nutr. 2001, 131(9):2515s-2522s.
41. Niwa T. Indoxyl sulfate is a nephro-vascular toxin. J. Ren. Nutr. 2010, 20(5 Suppl):S2-6.
42. Niwa T., Shimizu H. Indoxyl sulfate induces nephrovascular senescence. J. Ren. Nutr. 2012, 22(1):102-106.
43. Oakman C., Tenori L., Biganzoli L., Santarpia L., Cappadona S., Luchinat C., Di Leo A. Uncovering the metabolomic fingerprint of breast cancer. Int. J. Biochem. Cell Biol. 2011, 43(7):1010-1020.
44. 1H-NMR-based metabonomics. Int. J. Cancer 2005, 113(5):782-788.
45. Phoenix J., Wray S. Changes in human and rat uterine phosphoethanolamine and taurine with pregnancy and parturition. Exp. Physiol. 1994, 79(4):601-604.
46. Pirimoglu Z.M., Arslan C., Buyukbayrak E.E., Kars B., Karsidag Y.K., Unal O., Turan M.C. Glucose tolerance of premenopausal women after menopause due to surgical removal of ovaries. Climacteric 2011, 14(4):453-457.
47. Reckelhoff J.F., Fortepiani L.A. Novel mechanisms responsible for postmenopausal hypertension. Hypertension 2004, 43(5):918-923.
48. Murray, Robert K., D.K.G., Mayes, Peter A., Rodwell, Victor W., 2003. Harper's Illustrated Biochemistry, 26th ed. 140.
49. Santollo J., Wiley M.D., Eckel L.A. Acute activation of ER alpha decreases food intake, meal size, and body weight in ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293(6):R2194-R2201.
50. Sato B., Yoshikawa D., Ishii H., Kikuchi R., Arima T., Takeshita K., Inoue Y., Suzuki S., Tanaka M., Kumagai S., Matsumoto M., Hayashi M., Ando H., Amano T., Matsubara T., Niwa T., Murohara T. Indoxyl sulfate, a uremic toxin, and carotid intima-media thickness in patients with coronary artery disease. Int. J. Cardiol. 2013, 163(2):214-216.
51. Schneider B.P., Radovich M., Flockhart D.A., Carpenter J.S., Li L., Robarge J.D., Storniolo A.M., Hancock B.A., Skaar T.C., Sledge G.W. Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes. Breast Cancer Res. Treat. 2009, 116(3):543-549.
52. Serganova I., Rizwan A., Ni X., Thakur S.B., Vider J., Russell J., Blasberg R., Koutcher J.A. Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype. Clin. Cancer Res. 2011, 17(19):6250-6261.
53. Shearer J., Duggan G., Weljie A., Hittel D.S., Wasserman D.H., Vogel H.J. Metabolomic profiling of dietary-induced insulin resistance in the high fat-fed C57BL/6J mouse. Diabetes Obes. Metab. 2008, 10(10):950-958.
54. Shen Y., Li Y.Q., Li S.P., Ma L., Ding L.J., Ji H. Alleviation of ovariectomy-induced osteoporosis in rats by Panax notoginseng saponins. J. Nat. Med. 2010, 64(3):336-345.
55. Sipe K., Leventhal L., Burroughs K., Cosmi S., Johnston G.H., Deecher D.C. Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction. Brain Res. 2004, 1028(2):191-202.
56. Slupsky C.M., Steed H., Wells T.H., Dabbs K., Schepansky A., Capstick V., Faught W., Sawyer M.B. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers. Clin. Cancer Res. 2010, 16(23):5835-5841.
57. Song B., Zhang Z.Q. Effects of exercise and Nilestriol on bone size and bone mass in ovariectomized rats. Sichuan Da Xue Xue Bao Yi Xue Ban 2011, 42(4):519-522.
58. Taylor H.S., Manson J.E. Update in hormone therapy use in menopause. J. Clin. Endocrinol. Metab. 2011, 96(2):255-264.
59. Ubhi B.K., Riley J.H., Shaw P.A., Lomas D.A., Tal-Singer R., MacNee W., Griffin J.L., Connor S.C. Metabolic profiling detects biomarkers of protein degradation in COPD patients. Eur. Respir. J. 2012, 40(2):345-355.
60. Veeck J., Esteller M. Breast cancer epigenetics: from DNA methylation to microRNAs. J. Mammary Gland Biol. Neoplasia 2010, 15(1):5-17.
61. Villa P., Suriano R., Costantini B., Macri F., Ricciardi L., Campagna G., Lanzone A. Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation. Clin. Chem. Lab. Med. 2007, 45(2):130-135.
62. 1H NMR metabolomics data. Anal. Chem. 2006, 78(13):4430-4442.
63. Wojcik O.P., Koenig K.L., Zeleniuch-Jacquotte A., Costa M., Chen Y. Temporal reproducibility of taurine measurements in frozen serum of healthy postmenopausal women. Br. J. Nutr. 2010, 104(5):629-632.
64. Woodard G.A., Brooks M.M., Barinas-Mitchell E., Mackey R.H., Matthews K.A., Sutton-Tyrrell K. Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause 2011, 18(4):376-384.
65. Xu K., Liu H., Bi S., Yang S., Tan J. An endometrium morphometry study on ovariectomized rats subjected to Nilestriol and estradiol replalcement therapies. Hua Xi Yi Ke Da Xue Xue Bao 1998, 29(3):295-297.
66. Xue L., Wang Y., Liu L., Zhao L., Han T., Zhang Q., Qin L. A HNMR-based metabonomics study of postmenopausal osteoporosis and intervention effects of Er-Xian decoction in ovariectomized rats. Int. J. Mol. Sci. 2011, 12(11):7635-7651.
67. Yang K., Pan H.W., Jiang W.H. Renal protective effect of Nilestriol in aged women with hypertension. Hunan Yi Ke Da Xue Xue Bao 2003, 28(1):62-64.
68. Zhu X., Liu X., He P., Cao B., Lv Y., Zhang W., Ni X. Metabolomics in serum of ovariectomised rats and those exposed to 17beta-oestradiol and genistein. Gynecol. Endocrinol. 2010, 26(10):760-767.